Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer
Interdisciplinary CardioVascular and Thoracic Surgery · 02.11.2023 · 37 (5)
DOI: 10.1093/icvts/ivad152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 21.09.2023. Verfasst von Aritoshi Hattori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Smoking Research Foundation, National Cancer Center Research and Development Fund, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
OBJECTIVES We aimed to compare the outcomes of segmentectomy with those of lobectomy in T1c (>2–3 cm) radiological pure-solid non-small-cell lung cancer detected on thin-section computed tomography. METHODS This retrospective review compared the survival outcomes, causes of death and recurrence patterns between the segmentectomy and lobectomy in patients with c-T1cN0M0 radiological pure-solid non-small-cell lung cancer. Multivariable analysis was performed to control for confounders of survival. The overall survival (OS) and recurrence-free survival were analysed using the Kaplan–Meier method. Differences in cumulative incidence of recurrence between groups were assessed using the methods of Gray. RESULTS Of the 426 patients, lobectomy was performed in 381 patients and segmentectomy in 45 patients. Nodal metastasis was noted in 104 (24.4%) patients. Multivariable analysis revealed that lobectomy was an independent prognosticator of better OS (hazard ratio 0.596, 95% confidence interval 0.366–0.969; P = 0.037). Lobectomy arm showed favourable 5-year OS and recurrence-free survival (OS: 72.9% vs 59.7%, log-rank test P = 0.007; recurrence-free survival: 64.4% vs 48.7%, P = 0.034) (median follow-up: 53 months). Approximately 14% of the patients in the lobectomy group and 27% in the segmentectomy group died of lung cancer. Furthermore, 5-year cumulative incidence of loco-regional recurrence rate was significantly higher in the segmentectomy group (35.5% vs 15.8%, P < 0.001). CONCLUSIONS In T1c radiological pure-solid non-small-cell lung cancer, segmentectomy was significantly associated with worse survival and insufficient loco-regional cancer control. Lobectomy remains the standard surgical treatment; meanwhile, segmentectomy should be applied with great caution.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
ORCID-Profile: Kazuya Takamochi, Kenji Suzuki
Förderung
- Smoking Research Foundation
- National Cancer Center Research and Development Fund
- Japan Society for the Promotion of Science
Zitieren
APA
Hattori, A., Takamochi, K., Matsunaga, T., Fukui, M., & Suzuki, K. (2023). Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer. Interdisciplinary CardioVascular and Thoracic Surgery, 37(5). https://doi.org/10.1093/icvts/ivad152
Vancouver
Hattori A, Takamochi K, Matsunaga T, Fukui M, Suzuki K. Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer. Interdisciplinary CardioVascular and Thoracic Surgery. 2023;37(5). doi:10.1093/icvts/ivad152
BibTeX
@article{Hattori2023,
author = {Hattori, Aritoshi and Takamochi, Kazuya and Matsunaga, Takeshi and Fukui, Mariko and Suzuki, Kenji},
title = {Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2023},
volume = {37},
number = {5},
doi = {10.1093/icvts/ivad152}
}
EUVIMED